SUMMARY OBJECTIVE: This study aimed to compare the serum samples found reactive (≥1-≤20 signal-to-cutoff ratio) with Elecsys antibodies to hepatitis C virus screening test with innogenetics-line immunassay hepatitis C Virus Score test and to determine the most appropriate threshold value for...
ABSTRACT According to the World Health Organization, 71 million people live with chronic hepatitis C. The treatment of this disease requires assistance from specialized physicians and a highly complex health care system. The prison population has been recognized as being at a high risk of acquiring confi...
Introducción: Hoy día, las enfermedades infecciosas constituyen una de las causas de muerte más frecuentes, de ahí que la actual epidemia de hepatitis es un problema de salud a escala mundial. Las hepatitis B y C se propagan por medio del contacto con la sangre, el semen u otro líquido corporal de u...
Abstract The clinical management of hepatitis C virus (HCV) infection presents several challenges today. WHO's goal is to eliminate it by 2030. It is an ambitious goal and difficult to meet given the barriers to care that arise. This is possible today thanks to the discovery of direct-acting antivirals (...
INTRODUCCIÓN: La medición de carga viral (CV) de virus hepatitis B (VHB) y C (VHC) es fundamental en el seguimiento de pacientes con terapia antiviral. La metodología más utilizada para su determinación es COBAS ®-TaqMan ®. Recientemente, se desarrolló la tecnología Xpert ®, que se debe evaluar...
Resumen La principal infección viral transmisible por sangre es actualmente la debida al virus de hepatitis C (VHC). Uno de los mayores obstáculos para el logro de su control en la Argentina se relaciona con las dificultades de acceso al diagnóstico y tratamiento oportuno de las personas infectadas. E...
Abstract In addition to liver disease, the hepatitis C virus (HCV) has been associated with autoimmune phenomena, such as mixed cryoglobulin and glomerulonephritis (GN). Until recently, both chronic hepatitis and HCV extra-hepatic manifestations were treated with peg-interferon plus ribavirin, however th...
Lourenço, Mariana Sandoval;
Zitelli, Patricia Momoyo Y.;
Cunha-Silva, Marlone;
Oliveira, Arthur Ivan N.;
Lima, Roque Gabriel Rezende de;
Souza, Evandro de Oliveira;
Oliveira, Claudia P.;
Sevá-Pereira, Tiago;
Carrilho, Flair J.;
Pessoa, Mario G.;
Mazo, Daniel F..
OBJECTIVES: Despite higher rates of sustained virologic response (SVR), important concerns remain when patients with decompensated cirrhosis due to hepatitis C virus (HCV) are treated with direct-acting antiviral agents (DAA). Questions include efficacy, safety, and the magnitude of liver function improv...
Zitelli, Patricia Momoyo Yoshimura;
Gomes-Gouvêa, Michele;
Mazo, Daniel F.;
Singer, Julio da Motta;
Oliveira, Claudia P.M.S.;
Farias, Alberto Queiroz;
Pinho, João Renato;
Tanigawa, Ryan Yukimatsu;
Alves, Venâncio Avancini Ferreira;
Carrilho, Flair José;
Pessoa, Mário Guimarães.
OBJECTIVES: Co-infection with hepatitis A or B viruses may aggravate liver injury in patients infected with hepatitis C virus (HCV). However, few studies have assessed co-infection with hepatitis E virus (HEV) and HCV. Therefore, this study aimed to assess the prevalence and impact of HEV infection among...
Coinfección,
Diabetes Mellitus/epidemiología,
Hepacivirus/genética,
Anticuerpos Antihepatitis,
Hepatitis C,
Hepatitis C Crónica/complicaciones,
Virus de la Hepatitis E/genética,
Hepatitis E/complicaciones,
Hepatitis E/epidemiología,
Prevalencia,
ARN Viral
Abstract INTRODUCTION: We compared the hepatitis C virus (HCV) core antigen test with the HCV RNA assay to confirm anti-HCV results to determine whether the HCV core antigen test could be used as an alternative confirmatory test to the HCV RNA test. METHODS: Sera from 156 patients were analyzed for an...
